Selenoprotein P is not elevated in gestational diabetes mellitus

Gynecological Endocrinology

Volumn 31, Issue 11, 2015, Pages 874-876

  Altinova, Alev E ^a   Iyidir, Ozlem T ^a   Ozkan, Cigdem ^a   Ors, Damla ^a   Ozturk, Merve ^a   Gulbahar, Ozlem ^a   Bozkurt, Nuray ^a   Toruner, Fusun B ^a   Akturk, Mujde ^a   Cakir, Nuri ^a   Arslan, Metin ^a  

^a GAZI UNIVERSITY   (Turkey)

Author keywords

BMI; gestational diabetes mellitus; glucose; HDL cholesterol; lipids; selenoprotein P

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; SELENOPROTEIN P; TRIACYLGLYCEROL; CHOLESTEROL; GLUCOSE BLOOD LEVEL;

ADULT; ARTICLE; BODY MASS; CHOLESTEROL BLOOD LEVEL; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; FEMALE; GESTATIONAL AGE; HUMAN; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; METABOLIC PARAMETERS; ORAL GLUCOSE TOLERANCE TEST; PREGNANCY DIABETES MELLITUS; PREGNANT WOMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; BLOOD; CASE CONTROL STUDY; ENZYME IMMUNOASSAY; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE TEST; METABOLISM; PREGNANCY; TURKEY;

ADULT; BLOOD GLUCOSE; BODY MASS INDEX; CASE-CONTROL STUDIES; CHOLESTEROL; CHOLESTEROL, HDL; CHOLESTEROL, LDL; DIABETES, GESTATIONAL; FEMALE; GLUCOSE TOLERANCE TEST; HUMANS; IMMUNOENZYME TECHNIQUES; INSULIN RESISTANCE; PREGNANCY; SELENOPROTEIN P; TRIGLYCERIDES; TURKEY;

EID: 84949539994     PISSN: 09513590     EISSN: 14730766     Source Type: Journal    
DOI: 10.3109/09513590.2015.1103220     Document Type: Article

References (20)

1. American Diabetes Association. Gestational diabetes mellitus. Diabetes Care 2003; 26: S103-5
2. Metzger BE, Lowe LP, Dyer AR, et al. HAPO Study Cooperative Research Group. Hyperglycemia and adverse pregnancy outcomes. N Engl J Med 2008; 358: 1991-2002
3. Harlev A, Wiznitzer A. New insights on glucose pathophysiology in gestational diabetes and insulin resistance. Curr Diab Rep 2010; 10: 242-7
4. Stefan N, Häring HU. The role of hepatokines in metabolism. Nat Rev Endocrinol 2013; 9: 144-52
5. Hill KE, Wu S, Motley AK, et al. Production of selenoprotein P (Sepp1) by hepatocytes is central to selenium homeostasis. J Biol Chem 2012; 287: 40414-24
6. Misu H, Takamura T, Takayama H, et al. A liver-derived secretory protein, selenoprotein P, causes insulin resistance. Cell Metab 2010; 12: 483-95
7. Yang SJ, Hwang SY, Choi HY, et al. Serum selenoprotein P levels in patients with type 2 diabetes and prediabetes: implications for insulin resistance, inflammation, and atherosclerosis. J Clin Endocrinol Metab 2011; 96: E1325-9
8. Zhang Y, Chen X. Reducing selenoprotein P expression suppresses adipocyte differentiation as a result of increased preadipocyte inflammation. Am J Physiol Endocrinol Metab 2011; 300: E77-85
9. Choi HY, Hwang SY, Lee CH, et al. Increased selenoprotein p levels in subjects with visceral obesity and nonalcoholic fatty liver disease. Diabetes Metab J 2013; 37: 63-71
10. Roman M, Lapolla A, Jitaru P, et al. Plasma selenoproteins concentrations in type 2 diabetes mellitus-a pilot study. Transl Res 2010; 156: 242-50
11. Retnakaran R, Austin PC, Shah BR. Effect of subsequent pregnancies on the risk of developing diabetes following a first pregnancy complicated by gestational diabetes: a population-based study. Diabet Med 2011; 28: 287-92
12. Catalano PM, Huston L, Amini SB, Kalhan SC. Longitudinal changes in glucose metabolism during pregnancy in obese women with normal glucose tolerance and gestational diabetes mellitus. Am J Obstet Gynecol 1999; 180: 903-16
13. Coate KC, Smith MS, Shiota M, et al. Hepatic glucose metabolism in late pregnancy: normal versus high-fat and -fructose diet. Diabetes 2013; 62: 753-61
14. Farhan S, Handisurya A, Todoric J, et al. Fetuin-A characteristics during and after pregnancy: result from a case control pilot study. Int J Endocrinol 2012; 2012: 896736
15. Stein S, Stepan H, Kratzsch J, et al. Serum fibroblast growth factor 21 levels in gestational diabetes mellitus in relation to insulin resistance and dyslipidemia. Metabolism 2010; 59: 33-7
16. Koyama H, Abdulah R, Ohkubo T, et al. Depressed serum selenoprotein P: possible new predicator of increased risk for cerebrovascular events. Nutr Res 2009; 29: 94-9
17. Huang K, Liu H, Chen Z, Xu H. Role of selenium in cytoprotection against cholesterol oxide-induced vascular damage in rats. Atherosclerosis 2002; 162: 137-44
18. Stranges S, Tabák AG, Guallar E, et al. Selenium status and blood lipids: the cardiovascular risk in Young Finns study. J Intern Med 2011; 270: 469-77
19. Misu H, Ishikura K, Kurita S, et al. Inverse correlation between serum levels of selenoprotein P and adiponectin in patients with type 2 diabetes. PLoS One 2012; 7: e34952
20. Combs GF Jr, Watts JC, Jackson MI, et al. Determinants of selenium status in healthy adults. Nutr J 2011; 10: 75